Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,744.00
Bid: 4,744.00
Ask: 4,746.00
Change: -146.00 (-2.99%)
Spread: 2.00 (0.042%)
Open: 4,884.00
High: 4,884.00
Low: 4,744.00
Prev. Close: 4,890.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Nov 2009 07:00

RNS Number : 5998C
Intertek Group PLC
17 November 2009
 



17 November 20097:00am (UK) 

Intertek Group plc

Interim Management Statement

Intertek Group plc ("Intertek"), the leading provider of quality and safety services to a wide range of industries around the worldtoday releases its Interim Management Statement for the period 1 January 2009 to date. The full year results to 31 December 2009 will be announced on Monday 8 March 2010.

Overview

Total revenue growth for the ten month period to 31 October 2009 was 28% against the same period last year. At constant exchange rates, revenue growth was 8%, of which 4was organicMargins in each of the six divisions were stable compared to the half year reported margins. The weakness of sterling against many currencies, including the US dollar, Hong Kong dollar and Chinese renminbi, which comprise over half of group revenue, provided favourable exchange movement.

As expectedIntertek's rate of organic revenue growth is slowing ithe second half against the first half of 2009. This is mainly due to the spike in testing of children's products, which peaked at the end of 2008 and beginning of 2009, when inventory had to be tested to comply with the US toys legislation. Reduced demand for volume related inspection services continued in the Oil, Chemical & Agri division and there was sustained lower demand in the Minerals market. 

Three transactions for a total consideration of £29 million were completed to date as detailed in the half year accounts. The Group continues to explore opportunities for small and medium sized acquisitions in markets where the growth drivers are strong.

The year-to-date performance by division to 31 October 2009 is summarised below.

Consumer Goods continued to report high revenue growth of 40%. At constant exchange rates revenue growth was 15%, of which 11% was organicAs anticipated, as the year progressed, the growth rate reduced. This was due to the step up in growth that started in the second half of 2008 and ended in the first half of 2009, following the enactment of the Consumer Product Safety Improvement Act in the US, in which a high number of children's products in inventory were tested. This slowdown in the growth rate will continue through to the end of the first quarter of 2010.

Commercial & Electrical revenue grew by 25%. At constant exchange rates revenue growth was 2%, which was all from acquisitions made in the previous two calendar years. Organic revenue growth is improving from the first half due to growth in some industries.

 

Oil, Chemical & Agri revenue grew by 23%. At constant exchange rates revenue growth was 2%, all of which was organic. The division's growth rate continues to be impacted by reduced volumes of oil cargoes inspected as well as reduced volumes of cargoes inspected for Government contracts. Without the negative effect of the Government Services segment, the division would have grown by 5% organically at constant exchange rates, in line with the half year organic revenue growth. Laboratories that continue to face slower demand will be restructured.

The three smaller divisions reported high total growth largely due to the acquisitions made in the previous two calendar years. Analytical Services, grew by 17%, of which around 4% was organic at constant exchange rates. Industrial Servicesgrew by 91%, of which around 9% was organic at constant exchange rates. Minerals, grew by 7%, although it declined by 7% organically at constant exchange rates.

Commenting, Wolfhart Hauser, CEO Intertek, said:

"We continue to demonstrate our resilience in the face of challenging markets by growing organic revenue and operating profit year to date. This is despite the high comparables due to one-off testing in the Consumer Goods division and no improvement so far in the volume related business, which accounts for approximately 30% of the Group's revenue. 

Our long term structural drivers remain intact and we expect these to continue to drive good revenue growth next year."

Contacts 

Aston Swift / Sarah Ogilvie

Telephone: +44 (0) 20 7396 3400 

aston.swift@intertek.com / sarah.ogilvie@intertek.com

Richard Mountain / Sophie Kernon, Financial Dynamics

Telephone: +44 (0) 20 7831 3113

richard.mountain@fd.com / sophie.kernon@fd.com

Notes to Editors

ABOUT INTERTEK

Intertek is the leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers' products and processes, supporting their success in the global marketplace. Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and over 24,000 people in more than 100 countries around the world. 

Intertek is a FTSE 100 company listed on the London Stock Exchange. Ticker: ITRK

www.intertek.com 

This Interim Management Statement is prepared for and addressed only to the Company's shareholders as a whole and to no other person. The Company, its directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this Interim Management Statement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed. Statements contained in this Interim Management Statement are based on the knowledge and information available to the Company's Directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Interim Management Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Interim Management Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward-looking statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBIBDBIBBGGCL
Date   Source Headline
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSFinal Results
4th Jan 20221:00 pmRNSTotal Voting Rights
1st Dec 20211:00 pmRNSTotal Voting Rights
24th Nov 20217:00 amRNSTrading Statement
22nd Nov 20211:00 pmRNSBlock listing Interim Review
7th Sep 20214:10 pmRNSAcquisition
1st Sep 20211:00 pmRNSTotal Voting Rights
30th Jul 20217:00 amRNSHalf-year Report
21st Jul 20217:00 amRNSAcquisition
1st Jul 20217:00 amRNSDirector Declaration
1st Jul 20217:00 amRNSDirectorate Change
1st Jun 20211:00 pmRNSTotal Voting Rights
28th May 20211:00 pmRNSDirector/PDMR Shareholding
26th May 20211:00 pmRNSResult of AGM
26th May 20217:00 amRNSTrading Statement
24th May 20211:00 pmRNSBlock listing Interim Review
13th May 20217:00 amRNSAcquisition
26th Apr 20217:00 amRNSFirst CarbonZero Certification
1st Apr 20213:10 pmRNSDirector/PDMR Shareholding
1st Apr 20213:05 pmRNSDirectorate Change
24th Mar 20211:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20211:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20211:00 pmRNSDirector/PDMR Shareholding
19th Mar 20219:00 amRNSAnnual Financial Report
16th Mar 20217:00 amRNSDirector/PDMR Shareholding
15th Mar 20211:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSFinal Results
1st Mar 20211:00 pmRNSTotal Voting Rights
9th Feb 20217:30 amRNSDirector Declaration
5th Feb 20217:00 amRNSDirectorate Change
1st Feb 20217:00 amRNSDirectorate Change
4th Jan 20211:00 pmRNSTotal Voting Rights
18th Dec 20207:00 amRNSDirectorate Change
11th Dec 20207:00 amRNSDirectorate Change
1st Dec 20201:00 pmRNSTotal Voting Rights
24th Nov 20201:00 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSTrading Statement
23rd Nov 20203:00 pmRNSBlock listing Interim Review
2nd Nov 20201:00 pmRNSTotal Voting Rights
12th Oct 20201:00 pmRNSDirector Declaration
5th Oct 20207:00 amRNSDirectorate Change
1st Oct 20201:00 pmRNSTotal Voting Rights
1st Sep 20201:00 pmRNSTotal Voting Rights
25th Aug 20201:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.